9/23/2026
NeuroThera expands U.S. patent portfolio with ibogaine
Collaboration with Clearmind Medicine enhances therapeutic potential for mental health and substance use disorders.
Topic archive
psychedelic compounds
2 stories
8/19/2026
Psyence BioMed supports U.S. push for ibogaine development
U.S. federal actions could accelerate ibogaine's medical potential